Your browser doesn't support javascript.
loading
ST3GAL1 and ßII-spectrin pathways control CAR T cell migration to target tumors.
Hong, Yeonsun; Walling, Brandon L; Kim, Hye-Ran; Serratelli, William S; Lozada, John R; Sailer, Cooper J; Amitrano, Andrea M; Lim, Kihong; Mongre, Raj Kumar; Kim, Kyun-Do; Capece, Tara; Lomakina, Elena B; Reilly, Nicholas S; Vo, Kevin; Gerber, Scott A; Fan, Tan-Chi; Yu, Alice Lin-Tsing; Oakes, Patrick W; Waugh, Richard E; Jun, Chang-Duk; Reagan, Patrick M; Kim, Minsoo.
Afiliação
  • Hong Y; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Walling BL; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Kim HR; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Serratelli WS; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Lozada JR; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Sailer CJ; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Amitrano AM; Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA.
  • Lim K; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Mongre RK; Department of Pathology, University of Rochester Medical Center, Rochester, NY, USA.
  • Kim KD; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Capece T; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Lomakina EB; Department of Convergent Research of Emerging Virus Infection, Korea Research Institute of Chemical Technology, Daejeon, Korea.
  • Reilly NS; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Vo K; Department of Biomedical Engineering, University of Rochester Medical Center, Rochester, NY, USA.
  • Gerber SA; Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA.
  • Fan TC; Department of Microbiology and Immunology, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester, Rochester, NY, USA.
  • Yu AL; Department of Surgery, University of Rochester, Rochester, NY, USA.
  • Oakes PW; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.
  • Waugh RE; Department of Pediatrics/Hematology Oncology, University of California in San Diego, San Diego, CA, USA.
  • Jun CD; Department of Physics and Astronomy, University of Rochester, Rochester, NY, USA.
  • Reagan PM; Department of Biomedical Engineering, University of Rochester Medical Center, Rochester, NY, USA.
  • Kim M; School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju, Korea.
Nat Immunol ; 24(6): 1007-1019, 2023 06.
Article em En | MEDLINE | ID: mdl-37069398

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article